Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours
Journal of Neuroendocrinology · 2024
DOI: 10.1111/jne.13391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2024. Verfasst von Maria Wedin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Intestinal Neoplasms, Lymphatic Metastasis, Neuroendocrine Tumors, Octreotide. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Metastases outside the liver and abdominal/retroperitoneal lymph nodes are nowadays detected frequently in patients with neuroendocrine tumours (NETs), owing to the high sensitivity of positron emission tomography (PET) with Gallium‐68‐DOTA‐somatostatin analogues ( 68 Ga‐SSA) and concomitant diagnostic computed tomography (CT). Our aim was to determine the prevalence of extra‐abdominal metastases on 68 Ga‐DOTATOC‐PET/CT in a cohort of patients with small intestinal (Si‐NET) and pancreatic NET (Pan‐NET), as well as that of pancreatic metastasis in patients with Si‐NET. Among 2090 patients examined by 68 Ga‐DOTATOC‐PET/CT at two tertiary referral centres, a total of 1177 patients with a history of Si‐ or Pan‐NET, were identified. The most recent 68 Ga‐DOTATOC‐PET/CT report for each patient was reviewed, and the location and number of metastases of interest were recorded. Lesions outside the liver and abdominal nodes were found in 26% of patients ( n = 310/1177), of whom 21.5% (255/1177) were diagnosed with Si‐NET and 4.5% (55/1177) Pan‐NET. Bone metastases were found in 18.4% (215/1177), metastases to Virchow's lymph node in 7.1% (83/1177), and lung/pleura in 4.8% (56/1177). In the subset of 255 Si‐NET patients, 5.4% (41/255) manifested lesions in the pancreas, 1.5% in the breast (18/255), 1.3% in the heart (15/255) and 1% in the orbita (12/255). In Si‐NET patients, the Ki‐67 proliferation index was higher in those with ≥2 metastatic sites of interest, than with 1 metastatic site, ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
- Department of Medical Sciences, Endocrine Oncology unit, Uppsala University, Uppsala, Sweden.
- Department of Surgical Sciences, Radiology and Molecular Imaging, Uppsala University, Uppsala, Sweden.
- 2nd Department of Surgery, 'Korgialenio-Benakio', Red Cross General Hospital, Athens, Greece.
ORCID-Profile: Maria Wedin, Anders Sundin
Zitieren
APA
Wedin, M., Janson, E. T., Wallin, G., Sundin, A., & Daskalakis, K. (2024). Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13391
Vancouver
Wedin M, Janson ET, Wallin G, Sundin A, Daskalakis K. Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours. Journal of Neuroendocrinology. 2024. doi:10.1111/jne.13391
BibTeX
@article{Wedin2024,
author = {Wedin, Maria and Janson, Eva Tiensuu and Wallin, Göran and Sundin, Anders and Daskalakis, Kosmas},
title = {Prevalence of metastases outside the liver and abdominal lymph nodes on 68 Ga‐DOTATOC‐PET / CT in patients with small intestinal and pancreatic neuroendocrine tumours},
journal = {Journal of Neuroendocrinology},
year = {2024},
doi = {10.1111/jne.13391}
}
EUVIMED